CASC3 and Miyoshi myopathy: In contrast, overexpression of SRC-3 abrogated BTZ-induced MM apoptosis, as evidenced by anabatic-cleaved PARP and following the use of another proteasome inhibitor, carfilzomib (CFZ) (Fig. 3h).